Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$13.69 USD
+0.11 (0.81%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $13.66 -0.03 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -1.68 |
EPS Last Quarter | -1.80 |
Last EPS Surprise | -10.43% |
ABR | 2.67 |
Earnings ESP
|
0.48% |
---|---|
Current Year | -6.49 |
Next Year | -4.74 |
EPS (TTM) | -7.84 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.23M | 9.63M | 39.06M | 173.52M |
# of Estimates | 11 | 11 | 12 | 12 |
High Estimate | 13.90M | 17.90M | 59.90M | 584.56M |
Low Estimate | 5.00M | 6.70M | 26.02M | 65.71M |
Year ago Sales | 2.47M | 2.72M | 86.46M | 39.06M |
Year over Year Growth Est. | 233.00% | 254.19% | -54.82% | 344.22% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.68 | -1.62 | -6.49 | -4.74 |
# of Estimates | 13 | 11 | 14 | 14 |
Most Recent Consensus | -2.00 | -2.01 | -7.98 | -7.01 |
High Estimate | -1.42 | -1.32 | -5.66 | 3.59 |
Low Estimate | -2.04 | -1.90 | -7.36 | -7.01 |
Year ago EPS | -2.68 | -2.81 | -9.05 | -6.49 |
Year over Year Growth Est. | 37.31% | 42.35% | 28.29% | 27.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 2 | 1 | 3 |
Up Last 30 Days | 2 | 3 | 2 | 4 |
Up Last 60 Days | 3 | 4 | 4 | 6 |
Down Last 7 Days | 4 | 4 | 6 | 3 |
Down Last 30 Days | 5 | 4 | 7 | 4 |
Down Last 60 Days | 5 | 4 | 7 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.68 | -1.62 | -6.49 | -4.74 |
7 Days Ago | -1.62 | -1.59 | -6.30 | -4.53 |
30 Days Ago | -1.56 | -1.53 | -6.11 | -4.36 |
60 Days Ago | -1.60 | -1.56 | -6.29 | -4.57 |
90 Days Ago | -1.85 | -1.78 | -6.04 | -4.82 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.67 | -1.62 | -6.57 | -4.71 |
Zacks Consensus Estimate | -1.68 | -1.62 | -6.49 | -4.74 |
Earnings ESP | 0.48% | 0.28% | -1.32% | 0.64% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.80 | -0.55 | -2.81 | -2.68 | NA |
Estimate | -1.63 | -1.18 | -2.64 | -2.53 | NA |
Difference | -0.17 | 0.63 | -0.17 | -0.15 | 0.04 |
Surprise | -10.43% | 53.39% | -6.44% | -5.93% | 7.65% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more